Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
Darshan Doshi, Chief Medical Officer for Image-Guided Therapy Devices at Philips, shared on LinkedIn:
”Proud to share that today at TCT 2025, Philips has announced the 3-year results from the iMODERN trial, the largest global study to date using Class IA-recommended iFR in heart attack patients with multi-vessel disease.
This late-breaking data confirms that treating additional blocked arteries during the initial procedure is just as safe as waiting for a follow-up, giving clinicians more flexibility to personalize care and potentially reduce additional hospital visits.
These results directly address a longstanding question in interventional cardiology and reinforce the evidence base for physiology-guided treatment strategies.
In addition, new results from the ILIAS ANOCA study, also presented at TCT, highlight the sustained benefits of physiology-guided assessment and tailored medical therapy for patients with angina but no obstructive coronary arteries.
Together, these studies underscore the value of integrating advanced physiology solutions in decision-making across the spectrum of cardiovascular care.
Congratulations to the iMODERN and ILIAS ANOCA teams, and sincere thanks to the investigators and patients who made this research possible.
Read more in the press release.”
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes